Will Alpha Teknova stock go up?

According to Danelfin AI, Alpha Teknova has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.09%) is -2.73% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Alpha Teknova stock?

The Alpha Teknova target price is $5.81 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Alpha Teknova stock right now?

Alpha Teknova has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (48.09%) is -2.73% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Alpha Teknova stock is a good buy .

Is Alpha Teknova undervalued right now?

Based on analysts, the average price target downside for Alpha Teknova is 0.00% (1Y). According to Danelfin AI, Alpha Teknova has today an AI Score of 4/10 (Hold Rating).

What was the price range of Alpha Teknova stock over the past 12 months?

The Alpha Teknova stock price range over the past 12 months has been $1.99 - $6.37.

What is going on with Alpha Teknova stock in the last 3 months?

The Alpha Teknova stock performance in the last quarter has been +98.29%.

Does Alpha Teknova offer dividend payments?

No, Alpha Teknova does not currently pay dividends.

What is the current market capitalization of Alpha Teknova?

Alpha Teknova's market cap is $310.42M, as of 2026-07-03 08:00.

Alpha Teknova Inc (TKNO) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

TKNO AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+7.06%
Direction and strength of recent price movements
Valuation+3.56%
How the stock is priced relative to its fundamentals
Earnings Quality+0.40%
Stability and reliability of reported earnings

Sentiment-9.82%
How analysts and the market view the stock
Size & Liquidity-1.87%
Company size and trading liquidity
Volatility-1.30%
How much the stock price tends to fluctuate
Profitability-0.75%
Profitability and operating efficiency metrics

TKNO probability advantage of beating the market (3M):

-2.73%

AI Score

Hold

Alpha Teknova (TKNO) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -2.73% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of TKNO (48.09%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
TKNO probability advantage of beating the market (3M)-2.73%
TKNO probability of beating the market (3M)48.09%

TKNO probability advantage of beating the market (3M): -2.73%

The AI-powered overall analysis of Alpha Teknova (TKNO) is based on the 28 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of TKNO:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Life Sciences Tools & Services	N/A	-7.44%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+4.96%
Technical	Technicals Impact (Long Tail)	-	N/A	+2.92%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-2.17%
Technical	Chart Pattern (504d)	figure_8	N/A	+1.87%
Fundamental	Beginning Cash (Millions)	5.91		-1.87%
Technical	Chart Pattern (252d)	figure_49	N/A	-1.44%
Technical	Chart Pattern (60d)	figure_169	N/A	+1.35%
Technical	Maximum Volatility	8.31%		-1.30%
Technical	Alpha Last Day	-0.01%		+1.30%
Technical	Upgrade to unlock			+1.01%
Technical	Upgrade to unlock			-1.00%
Sentiment	Upgrade to unlock			-0.99%
Fundamental	Upgrade to unlock			-0.95%
Technical	Upgrade to unlock			+0.95%

Rest of Alpha Signals: +0.07%

TKNO probability advantage of beating the market (3M)Total:-2.73%
TKNO AI Score

Significant changes Vs previous day

TKNO Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$5.81
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

TKNO Proven Hold Signal & Price Forecast

This is the price chart for TKNO from January 2, 2026 until today. The chart indicates, in yellow, the 86 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

TKNO Average Past Performance & Win Rate

Three months after its 456 Hold signals since July 2026, TKNO had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

456 Past TKNO Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+77.88%
Average Alpha				+59.62%
Win Rate (% Positive Perf.)				63.93%
% Positive Alpha				59.02%

TKNO Frequently Asked Questions

Will Alpha Teknova stock go up?
According to Danelfin AI, Alpha Teknova has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.09%) is -2.73% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Alpha Teknova stock?
Is it a good time to buy, sell, or hold Alpha Teknova stock right now?
Is Alpha Teknova undervalued right now?
What was the price range of Alpha Teknova stock over the past 12 months?
What is going on with Alpha Teknova stock in the last 3 months?
Does Alpha Teknova offer dividend payments?
What is the current market capitalization of Alpha Teknova?

Alpha Teknova Inc Company Profile

Alpha Teknova, Inc. is a leading entity in the realm of reagent production critical for research, discovery, development and commercialization of innovative therapies, vaccines, and molecular diagnostics both domestically in the United States and on a global scale. The essence of its product portfolio rests on an array of offerings including pre-poured media plates adept at cell growth and cloning; liquid media and nutritional supplements engineered for cellular expansion; along with molecular biology reagents devised for sample manipulation, resuspension, and purification.

In addition to these core offerings, Alpha Teknova extends its capabilities in providing lab essentials which comprises chemical formulations tailored to be applicable in biological research as well as drug discovery. Furthermore, the company offers bespoke clinical solutions that find use in the development and production of protein therapies, gene therapies, mRNA vaccines, including diagnostic kits.

In terms of clientele reach, Alpha Teknova serves an array of segments within the life sciences market—spanning from pharmaceutical and biotechnology companies to contract development and manufacturing organizations. It also caters to franchises involved in vitro diagnostics plus academic circles along with governmentally run research institutions.

The foundation year for this company traces back to 1996 while it bases its operations out of Hollitory located in California.

Sector:
Country:United States
Industry:
Address:2451 Bert Drive, Hollister
Employees:158
Website:teknova.com

Pros

High customer switching costs in validated processes

Recurring revenue from consumable product sales

Structural growth in biopharmaceutical development

Specialized manufacturing expertise and quality control

Diversified end-market customer base

Cons

Intense competition from larger, diversified suppliers

Vulnerability to raw material supply chain disruptions

High regulatory compliance and quality system costs

Capital intensity for manufacturing capacity expansion

Demand sensitivity to biopharma funding cycles

Company	AI Score	Compare
TECHBio-Techne Corp

Company	AI Score	Compare
TECHBio-Techne Corp

TKNO Stock AI Analysis